JP2018500878A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018500878A5 JP2018500878A5 JP2017523804A JP2017523804A JP2018500878A5 JP 2018500878 A5 JP2018500878 A5 JP 2018500878A5 JP 2017523804 A JP2017523804 A JP 2017523804A JP 2017523804 A JP2017523804 A JP 2017523804A JP 2018500878 A5 JP2018500878 A5 JP 2018500878A5
- Authority
- JP
- Japan
- Prior art keywords
- glycoprotein
- dengue virus
- antibody
- seq
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462074053P | 2014-11-02 | 2014-11-02 | |
| US62/074,053 | 2014-11-02 | ||
| PCT/US2015/058610 WO2016070178A1 (en) | 2014-11-02 | 2015-11-02 | Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018500878A JP2018500878A (ja) | 2018-01-18 |
| JP2018500878A5 true JP2018500878A5 (https=) | 2018-12-13 |
| JP6671364B2 JP6671364B2 (ja) | 2020-03-25 |
Family
ID=55858450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017523804A Expired - Fee Related JP6671364B2 (ja) | 2014-11-02 | 2015-11-02 | ワクチンおよび診断開発のための組換えデングウイルスについての方法および組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10398768B2 (https=) |
| EP (1) | EP3212672A4 (https=) |
| JP (1) | JP6671364B2 (https=) |
| KR (1) | KR20170075775A (https=) |
| CN (1) | CN107207619A (https=) |
| AU (1) | AU2015338859A1 (https=) |
| BR (1) | BR112017008952A2 (https=) |
| CA (1) | CA2966198A1 (https=) |
| MX (1) | MX2017005524A (https=) |
| MY (1) | MY179251A (https=) |
| SG (1) | SG11201703366RA (https=) |
| WO (1) | WO2016070178A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018026845A1 (en) * | 2016-08-01 | 2018-02-08 | Inbios International, Inc. | Immunoassay methods and compositions for detecting infection involving use of test antigens as cross-reactive control antigens |
| CN106632620B (zh) * | 2016-11-29 | 2019-08-23 | 菲鹏生物股份有限公司 | 登革病毒重组抗原及其制备方法和应用 |
| US11370830B2 (en) | 2017-04-07 | 2022-06-28 | The Rockefeller University | Neutralizing antibodies that bind to the zika virus domain III envelope region |
| CN110568190A (zh) * | 2019-08-30 | 2019-12-13 | 深圳国际旅行卫生保健中心 | 登革热病毒抗原、检测试剂、检测试纸、检测试剂盒及其使用方法 |
| WO2021102363A1 (en) * | 2019-11-20 | 2021-05-27 | The University Of North Carolina At Chapel Hill | Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development |
| US20250188130A1 (en) * | 2022-03-17 | 2025-06-12 | The University Of North Carolina At Chapel Hill | Compositions comprising modified flavivirus e glycoproteins and methods of making and using the same |
| CN116716322B (zh) * | 2023-05-12 | 2024-05-31 | 中山大学 | 一种denv-3全长感染性克隆及其构建方法与应用 |
| WO2024238948A2 (en) * | 2023-05-17 | 2024-11-21 | University Of Iowa Research Foundation | Dengue virus serotype-specific modulation of t cell responses |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4501729A (en) | 1982-12-13 | 1985-02-26 | Research Corporation | Aerosolized amiloride treatment of retained pulmonary secretions |
| CA1247080A (en) | 1983-03-08 | 1988-12-20 | Commonwealth Serum Laboratories Commission | Antigenically active amino acid sequences |
| CA2138997C (en) | 1992-06-25 | 2003-06-03 | Jean-Paul Prieels | Vaccine composition containing adjuvants |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| US7476390B2 (en) * | 2002-02-26 | 2009-01-13 | Maxygen, Inc. | Flavivirus antigens |
| EP1773403B1 (en) | 2004-07-09 | 2018-04-25 | The University of North Carolina At Chapel Hill | Alphavirus-based adjuvants |
| PL2589602T3 (pl) * | 2006-08-15 | 2016-11-30 | Rozwinięcie komponentów szczepionki przeciwko wirusowi dengi | |
| US9821050B2 (en) * | 2012-04-02 | 2017-11-21 | The University Of North Carolina At Chapel Hill | Chimeric dengue virus E glycoproteins comprising mutant domain I and domain II hinge regions |
| ES2745431T3 (es) * | 2013-06-26 | 2020-03-02 | Univ North Carolina Chapel Hill | Composiciones para vacunas contra el virus del dengue y su uso |
-
2015
- 2015-11-02 JP JP2017523804A patent/JP6671364B2/ja not_active Expired - Fee Related
- 2015-11-02 AU AU2015338859A patent/AU2015338859A1/en not_active Abandoned
- 2015-11-02 MY MYPI2017701472A patent/MY179251A/en unknown
- 2015-11-02 CN CN201580072021.7A patent/CN107207619A/zh active Pending
- 2015-11-02 MX MX2017005524A patent/MX2017005524A/es unknown
- 2015-11-02 EP EP15854399.1A patent/EP3212672A4/en not_active Withdrawn
- 2015-11-02 SG SG11201703366RA patent/SG11201703366RA/en unknown
- 2015-11-02 KR KR1020177014337A patent/KR20170075775A/ko not_active Withdrawn
- 2015-11-02 WO PCT/US2015/058610 patent/WO2016070178A1/en not_active Ceased
- 2015-11-02 US US15/523,899 patent/US10398768B2/en not_active Expired - Fee Related
- 2015-11-02 CA CA2966198A patent/CA2966198A1/en not_active Abandoned
- 2015-11-02 BR BR112017008952-1A patent/BR112017008952A2/en not_active Application Discontinuation
-
2019
- 2019-08-29 US US16/555,912 patent/US20200230224A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018500878A5 (https=) | ||
| Fougeroux et al. | Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity | |
| Sun et al. | The self-assembled nanoparticle-based trimeric RBD mRNA vaccine elicits robust and durable protective immunity against SARS-CoV-2 in mice | |
| CY1124202T1 (el) | Εμβολια ανασυνδυασμενου zika | |
| Pimentel et al. | Peptide nanoparticles as novel immunogens: design and analysis of a prototypic severe acute respiratory syndrome vaccine | |
| Malhi et al. | Immunization with a self-assembling nanoparticle vaccine displaying EBV gH/gL protects humanized mice against lethal viral challenge | |
| Krammer et al. | Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin | |
| Park et al. | Analyzing immune responses to varied mRNA and protein vaccine sequences | |
| Tamminen et al. | A comparison of immunogenicity of norovirus GII‐4 virus‐like particles and P‐particles | |
| JP2015524422A5 (https=) | ||
| Carignan et al. | Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine | |
| PH12018500199A1 (en) | Antibodies that potently neutralize hepatitis b virus and uses thereof | |
| RU2015155821A (ru) | Вакцины против малярии | |
| ZA202104213B (en) | Antibodies that neutralize hepatitis b virus and uses thereof | |
| NO20090178L (no) | Vaksiner for malaria | |
| RU2019107976A (ru) | Композиция вакцины | |
| Kim et al. | Influenza M2 virus-like particles confer a broader range of cross protection to the strain-specific pre-existing immunity | |
| Song et al. | Plant‐based, adjuvant‐free, potent multivalent vaccines for avian influenza virus via Lactococcus surface display | |
| JP2016504993A5 (https=) | ||
| RU2021109510A (ru) | Вакцинация с использованием альфа 3 домена mica/b для лечения рака | |
| Davenport et al. | Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease | |
| RU2016133598A (ru) | Композиция микобактериального антигена | |
| Abente et al. | Alphavirus-vectored hemagglutinin subunit vaccine provides partial protection against heterologous challenge in pigs | |
| Moreno et al. | Rabbit hemorrhagic disease virus capsid, a versatile platform for foreign B-cell epitope display inducing protective humoral immune responses | |
| JP2016528176A5 (https=) |